| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 3 | |||
| NCT07414758 | Golidocitinib Versus Placebo as Maintenance Therapy in PTCL Patients With Response… | Peripheral T Cell Lymphoma | Recruiting |
| NCT07300514 | Golidocitinib Versus Placebo as Maintenance Therapy for Peripheral T-Cell Lymphoma | Maintenance Treatment of Peripheral T-cell Lymphoma | Recruiting |
| NCT07234162 | A Phase 3 Multinational Study of Golidocitinib Versus Investigator's Choice in r/r PTCL… | Peripheral T-cell Lymphoma | Recruiting |
| Phase 2/3 | |||
| NCT07339345 | Prospective Single-Arm Clinical Trial of GO Regimen for HLH. | Lymphohistiocytosis, Hemophagocytic | Recruiting |
| NCT07369739 | Golidocitinib Combined With Selinexor for CAEBVD | Lymphohistiocytosis | Recruiting |
| Phase 2 | |||
| NCT06630091 | A Phase II, Single-center, Single-arm Study Evaluating the Safety and Efficacy of… | Peripheral T Cell Lymphoma | Recruiting |
| NCT07380984 | PD-1 Antibody-based Therapy With Concurrent RT for Early-stage NKTCL | Natural Killer/T-cell Lymphoma | Recruiting |
| NCT07303881 | Golidocitinib for Refractory Immune-related Hematologic Toxicities of Advanced Lung Cancer | IrAE | Not Yet Recruiting |
| Phase 1/2 | |||
| NCT07093710 | Golidocitinib Combined With Mitoxantrone Hydrochloride Liposome or Chidamide in the… | Peripheral T Cell Lymphoma | Recruiting |
| NCT07525466 | Combination of Mitoxantrone Liposome and Etoposide, Dexamethasone, Pegaspargase and… | Extranodal NK T Cell Lymphoma | Recruiting |
| NCT07339527 | EZH2 Inhibitor Zeprumetostat in Combination Therapy for Patients With Relapsed or… | Mature T-cell and NK-cell Lymphoma | Not Yet Recruiting |